NXTC · CIK 0001661059 · FY2025 live · 2025-12-31
NextCure, Inc.
View as
Model
Classic Z
FY2025
−13.78
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
6.55
0–100 · Classic Z tape · not a PD
Book standing
6
Year change
—
Market PD
—
O-score
8
Events on this name
Same published rows as Today. Not a live recompute.
MARKET PD UNAVAILABLE
watch · 41
- mertonPd: — → —
−13.78
Z″ −29.29
Score −13.78 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.661.2 × = 0.79X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−8.691.4 × = −12.16X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−1.153.3 × = −3.79X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
2.290.6 × = 1.38X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.001 × = 0.00
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
NextCure, Inc. is on classic Z at −13.78 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 11th percentile in Healthcare.
- SKYEDistressSkye Bioscience, Inc.−13.77
- BMEADistressBiomea Fusion, Inc.−13.87
- ICCMDistressIceCure Medical Ltd.−13.69
- TLSIDistressTriSalus Life Sciences, Inc.−13.93
- SNTIDistressSenti Biosciences Holdings, Inc.−13.94
- EDITDistressEditas Medicine, Inc.−13.98
- CVDistressCapsoVision, Inc−13.46
- GOSSDistressGossamer Bio, Inc.−14.21
KPI widgets
Current assets
$44M
Total assets
$50M
Current liabilities
$11M
Total liabilities
$15M
Working capital
$33M
Retained earnings
−$436M
EBIT
−$58M
Total sales
$0
Book equity
$35M
Accession 0001104659-26-024137. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.